PGIM Jennison Health Sciences Fund - Class A (PHLAX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
37.51
-0.08 (-0.21%)
At close: Dec 31, 2025
4.34%
Fund Assets1.56B
Expense Ratio1.13%
Min. Investment$1,000
Turnover79.00%
Dividend (ttm)5.05
Dividend Yield13.43%
Dividend Growth-5.01%
Payout FrequencyAnnual
Ex-Dividend DateDec 19, 2025
Previous Close37.59
YTD Return18.49%
1-Year Return18.46%
5-Year Return32.88%
52-Week Low27.54
52-Week High38.66
Beta (5Y)n/a
Holdings51
Inception DateJun 30, 1999

About PHLAX

PGIM Jennison Health Sciences Fund Class A is a mutual fund focused on long-term capital appreciation by investing primarily in equity and equity-related securities of U.S. companies within the healthcare sector. The fund targets firms engaged in pharmaceuticals, biotechnology, medical equipment, hospitals, nursing care, and health insurance carriers. With assets totaling approximately $1.68 billion and an expense ratio of about 1.13%, it offers exposure to a diversified portfolio of around 46 holdings, including prominent healthcare companies such as Eli Lilly, UnitedHealth Group, and Bristol-Myers Squibb. Since its inception in 1999, the fund has sought to leverage healthcare innovation and growth trends to deliver value, making it a specialized vehicle within the health sciences investment space. The fund pays dividends annually and maintains a focus on large growth companies in the health sector.

Fund Family PGIM Investments
Category Health
Performance Rating Above Average
Risk Rating Average
Stock Exchange NASDAQ
Ticker Symbol PHLAX
Share Class Class A
Index S&P Composite 1500 Health Care TR

Performance

PHLAX had a total return of 18.46% in the past year, including dividends. Since the fund's inception, the average annual return has been 20.70%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

SymbolShare ClassExpense Ratio
PHLQXClass R60.77%
PHSZXClass Z0.86%
PJHRXClass R1.48%
PHLCXClass C1.96%

Top 10 Holdings

51.23% of assets
NameSymbolWeight
Eli Lilly and CompanyLLY16.48%
Thermo Fisher Scientific Inc.TMO5.39%
Prudential Govt Money Mkt Fdn/a5.30%
Danaher CorporationDHR5.01%
argenx SEARGX4.62%
UCB SAUCB3.14%
Vertex Pharmaceuticals IncorporatedVRTX2.91%
Neurocrine Biosciences, Inc.NBIX2.90%
AstraZeneca PLCAZN2.80%
UnitedHealth Group IncorporatedUNH2.68%
View More Holdings

Dividend History

Ex-DividendAmountPay Date
Dec 19, 2025$5.04682Dec 19, 2025
Dec 20, 2024$5.31325Dec 20, 2024
Dec 20, 2023$1.91322Dec 20, 2023
Dec 20, 2022$0.61624Dec 20, 2022
Dec 20, 2021$14.02528Dec 20, 2021
Dec 20, 2019$1.43164Dec 20, 2019
Full Dividend History